glp-1 agonist dementia Role of glucagon-like peptide-1 receptor agonists in Alzheimer's disease and Parkinson's disease | Journal of Biomedical Science Mapping the effectiveness and risks

Semaglutide (Ozempic for diabetes, Wegovy for weight loss) represents the most effective pure GLP-1 agonist currently available

The black box warning was given to Ozempic because of the increased risk of thyroid C-cell tumors, including medullary thyroid carcinoma

Sitting upright after eating and avoiding lying down right away can make a big difference

Patients considering or currently using weight loss injections should understand that while some precautionary warnings exist, these medications have undergone rigorous testing and continue to be monitored for safety

Subcutaneous 3.1.1.1

Shaobo Ding, [email protected] These authors have contributed equally to this work This article was submitted to Experimental Pharmacology and Drug Discovery, a section of the journal Frontiers in Pharmacology Disclaimer All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers